Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

Daniela Iacono,1 Elvira Favoino,2 Alessia Borgia,1 Serena Fasano,1 Ilenia Pantano,1 Virginia D’Abrosca,1 Giuseppe Picillo,1 Rosa Daniela Grembiale,3 Federico Perosa,2 Gabriele Valentini1 1Department of Clinical and Experimental Medicine, Rheumatology Section, University of Campania &ld...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Iacono D, Favoino E, Borgia A, Fasano S, Pantano I, D'Abrosca V, Picillo G, Grembiale RD, Perosa F, Valentini G
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Rheumatoid Arthritis Mortality Anticarbamylated protein antibodies Death causes Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/e3d64f6401de43b68d1bc3b35bed63ee
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e3d64f6401de43b68d1bc3b35bed63ee
record_format	dspace
spelling	oai:doaj.org-article:e3d64f6401de43b68d1bc3b35bed63ee2021-12-02T07:26:20ZLow mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence1179-156Xhttps://doaj.org/article/e3d64f6401de43b68d1bc3b35bed63ee2018-09-01T00:00:00Zhttps://www.dovepress.com/low-mortality-rate-in-italian-rheumatoid-arthritis-patients-from-a-ter-peer-reviewed-article-OARRRhttps://doaj.org/toc/1179-156XDaniela Iacono,1 Elvira Favoino,2 Alessia Borgia,1 Serena Fasano,1 Ilenia Pantano,1 Virginia D’Abrosca,1 Giuseppe Picillo,1 Rosa Daniela Grembiale,3 Federico Perosa,2 Gabriele Valentini1 1Department of Clinical and Experimental Medicine, Rheumatology Section, University of Campania “Luigi Vanvitelli”, Naples, Italy; 2Department of Biomedical Sciences and Human Oncology (DIMO), Rheumatologic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari, Italy; 3Department of Medical and Surgical Sciences, University of Magna Graecia, Catanzaro, Italy Background and objective: Anti-carbamylated protein antibodies (anti-CarP Ab) represent a novel kind of autoantibodies specificity detectable in the sera of patients with rheumatoid arthritis (RA). They have been recently reported to be associated with increased mortality in Spanish patients with RA. The aim of our study was to compare the incidence mortality rates (IMRs) detected in RA patients from a tertiary Italian center with those reported in other European tertiary centers and to evaluate the putative role of anti-CarP Ab in modulating the low IMR detected in our patients.Methods: Clinical charts of patients consecutively admitted to our center, from January 1, 2008, to December 31, 2014, were retrospectively reviewed. The mortality rate (expressed as the number of deaths in the cohort divided by the number of years of IMR follow-up) and causes of death were assessed at December 31, 2015. Sera of 61 patients, representative of the whole cohort, collected at the time of admission to our center were investigated for the presence and the level of anti-CarP Ab. Demographic and clinical features, mortality rates and prevalence of anti-CarP Ab in our series were compared with those reported in other European cohorts.Results: We observed 608 patients for a median of 3.51 years. All-cause and cause-specific IMRs in our cohort were significantly lower than the Better Anti-rheumatic Farmaco-therapy and the Spanish cohort, while only all-cause and cardiovascular IMRs were significantly lower in our series with respect to the Leiden Early Arthritis Clinic cohort. Anti-CarP Ab prevalence was significantly lower in our series than in any other European cohorts.Conclusion: We confirm that the mortality rate is lower in our Italian RA cohort with respect to other European cohorts. Whether the low prevalence of anti-CarP Ab might be responsible for this result awaits to be furtherly investigated. Keywords: rheumatoid arthritis, mortality, anti-carbamylated protein antibodies, death causesIacono DFavoino EBorgia AFasano SPantano ID'Abrosca VPicillo GGrembiale RDPerosa FValentini GDove Medical PressarticleRheumatoid ArthritisMortalityAnticarbamylated protein antibodiesDeath causesDiseases of the musculoskeletal systemRC925-935ENOpen Access Rheumatology: Research and Reviews, Vol Volume 10, Pp 129-134 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Rheumatoid Arthritis Mortality Anticarbamylated protein antibodies Death causes Diseases of the musculoskeletal system RC925-935
spellingShingle	Rheumatoid Arthritis Mortality Anticarbamylated protein antibodies Death causes Diseases of the musculoskeletal system RC925-935 Iacono D Favoino E Borgia A Fasano S Pantano I D'Abrosca V Picillo G Grembiale RD Perosa F Valentini G Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
description	Daniela Iacono,1 Elvira Favoino,2 Alessia Borgia,1 Serena Fasano,1 Ilenia Pantano,1 Virginia D’Abrosca,1 Giuseppe Picillo,1 Rosa Daniela Grembiale,3 Federico Perosa,2 Gabriele Valentini1 1Department of Clinical and Experimental Medicine, Rheumatology Section, University of Campania “Luigi Vanvitelli”, Naples, Italy; 2Department of Biomedical Sciences and Human Oncology (DIMO), Rheumatologic and Systemic Autoimmune Diseases Unit, University of Bari Medical School, Bari, Italy; 3Department of Medical and Surgical Sciences, University of Magna Graecia, Catanzaro, Italy Background and objective: Anti-carbamylated protein antibodies (anti-CarP Ab) represent a novel kind of autoantibodies specificity detectable in the sera of patients with rheumatoid arthritis (RA). They have been recently reported to be associated with increased mortality in Spanish patients with RA. The aim of our study was to compare the incidence mortality rates (IMRs) detected in RA patients from a tertiary Italian center with those reported in other European tertiary centers and to evaluate the putative role of anti-CarP Ab in modulating the low IMR detected in our patients.Methods: Clinical charts of patients consecutively admitted to our center, from January 1, 2008, to December 31, 2014, were retrospectively reviewed. The mortality rate (expressed as the number of deaths in the cohort divided by the number of years of IMR follow-up) and causes of death were assessed at December 31, 2015. Sera of 61 patients, representative of the whole cohort, collected at the time of admission to our center were investigated for the presence and the level of anti-CarP Ab. Demographic and clinical features, mortality rates and prevalence of anti-CarP Ab in our series were compared with those reported in other European cohorts.Results: We observed 608 patients for a median of 3.51 years. All-cause and cause-specific IMRs in our cohort were significantly lower than the Better Anti-rheumatic Farmaco-therapy and the Spanish cohort, while only all-cause and cardiovascular IMRs were significantly lower in our series with respect to the Leiden Early Arthritis Clinic cohort. Anti-CarP Ab prevalence was significantly lower in our series than in any other European cohorts.Conclusion: We confirm that the mortality rate is lower in our Italian RA cohort with respect to other European cohorts. Whether the low prevalence of anti-CarP Ab might be responsible for this result awaits to be furtherly investigated. Keywords: rheumatoid arthritis, mortality, anti-carbamylated protein antibodies, death causes
format	article
author	Iacono D Favoino E Borgia A Fasano S Pantano I D'Abrosca V Picillo G Grembiale RD Perosa F Valentini G
author_facet	Iacono D Favoino E Borgia A Fasano S Pantano I D'Abrosca V Picillo G Grembiale RD Perosa F Valentini G
author_sort	Iacono D
title	Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
title_short	Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
title_full	Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
title_fullStr	Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
title_full_unstemmed	Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
title_sort	low mortality rate in italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/e3d64f6401de43b68d1bc3b35bed63ee
work_keys_str_mv	AT iaconod lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT favoinoe lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT borgiaa lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT fasanos lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT pantanoi lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT dabroscav lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT picillog lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT grembialerd lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT perosaf lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence AT valentinig lowmortalityrateinitalianrheumatoidarthritispatientsfromatertiarycenterputativeimplicationofalowanticarbamylatedproteinantibodiesprevalence
_version_	1718399432380121088

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence

Ejemplares similares